Among active 13F managers last quarter, 5 added and none reduced or exited; the largest holder to move was Renaissance Technologies LLC (+40%). No open-market insider trades in the last 180 days.
Funds lean in and no leg opposes.
20 tracked 13F filers disclose a position in BOLT as of the latest SEC 13F filings, a combined $2.0M in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Shares | Position value | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | Sofinnova Investments, Inc. | 138K | $530K | —Held | Q2 2026 | |
| 2 | Renaissance Technologies LLC | 77K | $312K | ▲+40% Added · +22K sh | Q1 2026 | |
| 3 | Vivo Capital, LLC | 72K | $279K | —Held | Q2 2026 | |
| 4 | Citadel Advisors LLC | 57K | $219K | ▲+463% Added · +47K sh | Q2 2026 | |
| 5 | Pfizer Inc | 31K | $134K | —Held | Q2 2026 | |
| 6 | Lynx1 Capital Management LP | 31K | $119K | —Held | Q2 2026 | |
| 7 | Nano Cap New Millennium Growth Fund L P | 28K | $106K | —Held | Q2 2026 | |
| 8 | Geode Capital Management, LLC | 19K | $74K | ▼−34% Reduced · −10K sh | Q2 2026 | |
| 9 | Shay Capital LLC | 15K | $59K | ▲+3.6% Added · +533 sh | Q2 2026 | |
| 10 | Susquehanna International Group, LLP | 12K | $47K | ▲New +12K sh | Q1 2026 | |
| 11 | BlackRock, Inc. | 10K | $37K | —Held | Q2 2026 | |
| 12 | Vanguard Capital Management LLC | 7K | $27K | —Held | Q2 2026 | |
| 13 | Morgan Stanley | 3K | $13K | ▲+1.9% Added · +61 sh | Q1 2026 | |
| 14 | Vanguard Fiduciary Trust Co | 3K | $12K | —Held | Q2 2026 | |
| 15 | NewEdge Advisors, LLC | 3K | $10K | ▲New +3K sh | Q2 2026 | |
| 16 | Tower Research Capital LLC (TRC) | 1K | $4K | ▲+51% Added · +370 sh | Q1 2026 | |
| 17 | UBS Group AG | 787 | $3K | ▲+53% Added · +272 sh | Q1 2026 | |
| 18 | SBI Securities Co., Ltd. | 130 | $501 | ▲13× Added · +120 sh | Q2 2026 | |
| 19 | JPMorgan Chase & Co | 42 | $179 | —Held | Q1 2026 | |
| 20 | Barclays PLC | 6 | $24 | —Held | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 5 funds added to an existing position in BOLT, while none reduced or exited. Based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Their position there |
|---|---|---|
| Servicenow IncNOW | 6 funds | $567.8M |
| Take-Two Interactive SoftwreTTWO | 6 funds | $520.5M |
| Thermo Fisher Scientific IncTMO | 6 funds | $371.9M |
| Zscaler IncZS | 6 funds | $178.9M |
| Figma Inc-CL AFIG | 6 funds | $151.7M |
| Dyne Therapeutics IncDYN | 6 funds | $106.7M |
| Kranesh Csi China InternetKWEB | 6 funds | $57.3M |
| Tenax Therapeutics IncTENX | 6 funds | $56.7M |
| Oric Pharmaceuticals IncORIC | 6 funds | $52.1M |
| Design Therapeutics IncDSGN | 6 funds | $41.4M |
| Wave Life Sciences LtdWVE | 6 funds | $19.2M |
| Nuvation Bio IncNUVB | 6 funds | $14.8M |
Ranked by how many of BOLT's tracked holders also hold each name. The last column is those co-holders' combined reported position in that name, not in BOLT.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Dec 5, 2025 | Nemec Sarah | Senior VP, Finance and PAO | Buy (P) | 125 | $576 |
| Dec 5, 2025 | Quinn William P. | President, CEO and CFO, Director | Buy (P) | 125 | $576 |
| Jun 6, 2025 | Quinn William P. | President, CEO and CFO, Director | Buy (P) | 125 | $686 |
| Jun 6, 2025 | Nemec Sarah | Senior VP, Finance and PAO | Buy (P) | 125 | $686 |
| Dec 16, 2024 | Quinn William P. | President, CEO and CFO, Director | Buy (P) | 3K | $1K |
| Dec 16, 2024 | Nemec Sarah | Senior VP, Finance and PAO | Buy (P) | 3K | $1K |
| Jun 6, 2024 | Quinn William P. | President, CEO and CFO, Director | Buy (P) | 3K | $2K |
| Jun 6, 2024 | Nemec Sarah | Senior VP, Finance and PAO | Buy (P) | 3K | $2K |
| Dec 12, 2023 | Quinn William P. | Chief Financial Officer | Buy (P) | 8K | $7K |
| Dec 6, 2023 | Quinn William P. | Chief Financial Officer | Buy (P) | 3K | $2K |
| Nov 30, 2023 | Engleman Edgar | Director | Sell (S) 2 lots, same day | 123K | $106K |
| Nov 29, 2023 | Engleman Edgar | Director | Sell (S) 2 lots, same day | 26K | $23K |
One row per insider, day and transaction code; shares and value are summed across the lots. Every lot is on the full insider page and in the filing.
Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.
Insiders and Congress: last 180 days. Funds: latest 13F, top 100 holders incl. passive
| Source | Buying | Selling | Net |
|---|---|---|---|
13F funds Top 100 holders by value, passive included; the hero counts active managers only | 7 | 1 | – |
Insiders Form 4 open-market | 0 | 0 | $0 |
US House STOCK Act trades | 0 | 0 | $0 |
Capital Rotation reports where institutional capital disclosed rotating, as of the latest public SEC 13F filings. It is data, not investment advice, a recommendation, or a prediction. Filings lag about 45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.
Connected entities for BOLT
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/BOLT/capital-change-brief"
Use Arkolith's capital_change_brief for BOLT. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for BOLT. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.